Sharehope Medicine Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
August 13, 2020 at 06:39 pm
Share
ShareHope Medicine Co., Ltd. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced total revenue was TWD 956.071 million compared to TWD 780.812 million a year ago. Operating income was TWD 140.913 million compared to TWD 53.148 million a year ago. Net income was TWD 75.847 million compared to TWD 66.070 million a year ago. Basic earnings per share was TWD 0.74 compared to TWD 0.65 a year ago. Diluted earnings per share was TWD 0.72 compared to TWD 0.63 a year ago. For the half year, total revenue was TWD 1,798.519 million compared to TWD 1,534.845 million a year ago. Operating income was TWD 166.949 million compared to TWD 66.490 million a year ago. Net income was TWD 37.230 million compared to TWD 86.865 million a year ago. Basic earnings per share was TWD 0.36 compared to TWD 0.85 a year ago. Diluted earnings per share was TWD 0.35 compared to TWD 0.78 a year ago.
ShareHope Medicine Co., Ltd. is principally engaged in the supply of pharmaceuticals, medical materials and technology materials. The Company is also engaged in the provision of medical health check and medical testing laboratories management consulting and entrusted operation services, the leasing of equipment and the provision of long-term care services. The Company operates its business through five segments: pharmaceutical distribution, health management, technology materials, hospitals and others. The Company distributes its products within domestic market and to overseas markets.
SHAREHOPE MEDICINE CO., LTD. 
